Logo image of PCAA-P.CA

PC 1 CORP (PCAA-P.CA) Stock Fundamental Analysis

TSX-V:PCAA-P - TSX Venture Exchange - CA69323W1041 - Common Stock - Currency: CAD

0.025  0 (-16.67%)

Fundamental Rating

2

Overall PCAA-P gets a fundamental rating of 2 out of 10. We evaluated PCAA-P against 0 industry peers in the Unkown industry. PCAA-P has a great financial health rating, but its profitability evaluates not so good. PCAA-P does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PCAA-P had negative earnings in the past year.
PCAA-P had a negative operating cash flow in the past year.
PCAA-P.CA Yearly Net Income VS EBIT VS OCF VS FCFPCAA-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20K -40K -60K -80K

1.2 Ratios

Industry RankSector Rank
ROA -9.57%
ROE -9.85%
ROIC N/A
ROA(3y)-9.98%
ROA(5y)N/A
ROE(3y)-10.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCAA-P.CA Yearly ROA, ROE, ROICPCAA-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -2 -4 -6 -8 -10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PCAA-P so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCAA-P.CA Yearly Profit, Operating, Gross MarginsPCAA-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for PCAA-P remains at a similar level compared to 1 year ago.
PCAA-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PCAA-P.CA Yearly Shares OutstandingPCAA-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
PCAA-P.CA Yearly Total Debt VS Total AssetsPCAA-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 100K 200K 300K 400K 500K

2.2 Solvency

An Altman-Z score of 15.54 indicates that PCAA-P is not in any danger for bankruptcy at the moment.
PCAA-P has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.54
ROIC/WACCN/A
WACCN/A
PCAA-P.CA Yearly LT Debt VS Equity VS FCFPCAA-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100K 200K 300K 400K 500K

2.3 Liquidity

PCAA-P has a Current Ratio of 34.96. This indicates that PCAA-P is financially healthy and has no problem in meeting its short term obligations.
PCAA-P has a Quick Ratio of 34.96. This indicates that PCAA-P is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 34.96
Quick Ratio 34.96
PCAA-P.CA Yearly Current Assets VS Current LiabilitesPCAA-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100K 200K 300K 400K 500K

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.56% over the past year.
EPS 1Y (TTM)20.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCAA-P.CA Yearly Revenue VS EstimatesPCAA-P.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024
PCAA-P.CA Yearly EPS VS EstimatesPCAA-P.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
PCAA-P.CA Price Earnings VS Forward Price EarningsPCAA-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCAA-P.CA Per share dataPCAA-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PCAA-P does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PC 1 CORP

TSX-V:PCAA-P (3/5/2025, 7:00:00 PM)

0.025

0 (-16.67%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap258.75K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.64
P/tB 0.64
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.57%
ROE -9.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.98%
ROA(5y)N/A
ROE(3y)-10.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 34.96
Quick Ratio 34.96
Altman-Z 15.54
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.9%
OCF growth 3YN/A
OCF growth 5YN/A